The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
Read Also
- Rogues in Love (Tuesday Crossword, May 21)
- When Taiwan changed leader, Beijing sent its own guests, uninvited
- Airport in Haiti's capital reopens after months of gang violence, helping to ease humanitarian crisis
- All the Republicans who have signaled they won’t accept election results
- Thunderstorm warnings for Northern Ireland and south-west England
- Rudy Giuliani complains Arizona indictment not served ‘stylishly’
- Netanyahu compares ICC arrest warrant request to anti-Israel protests: ‘What the new antisemitism looks like’
- Auto theft a serious issue for makers, RCMP says as feds unveil action plan
- JPMorgan CEO Jamie Dimon signals retirement is closer than ever
- Ebrahim Raisi, Iran’s President, Is Dead at 63
Latest CNBC
- JPMorgan CEO Jamie Dimon signals retirement is closer than ever
- Microsoft announces new PCs with AI chips from Qualcomm
- Exxon faces opposition from CalPERS after 'devastating' anti-ESG activist suit
- Shares of Hims & Hers Health surge 30% after startup says it will offer GLP-1 injections
- WikiLeaks founder Julian Assange can appeal extradition to U.S., UK court rules
- International Criminal Court seeks arrest warrants for Israeli PM Netanyahu, three Hamas leaders
- Britain expands AI safety institute to San Francisco amid scrutiny over regulatory shortcomings
- Iran's President Raisi is dead. What does the leadership void mean for the country and the world?
- UK stocks are outperforming the U.S. and one CIO says they look 'very cheap'
- $9 billion travel tech firm Navan on track to hit profitability this year and 'not far' from IPO, CEO says